Pharmacological Reviews xPharm- The Comprehensive Pharmacology Reference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Piñeyro, G.
Right arrow Articles by Blier, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Piñeyro, G.
Right arrow Articles by Blier, P.

Vol. 51, Issue 3, 533-591, September 1999

Autoregulation of Serotonin Neurons: Role in Antidepressant Drug Action

Graciela Piñeyro and Pierre Blier1

Department of Psychiatry, Neurobiological Psychiatry Unit, McGill University, Montreal, Quebec, Canada

I. Introduction
II. Morphological Aspects of the 5-HT Rostral System
    A. 5-HT Nuclei
        1. The Caudal Linear Nucleus.
        2. The Dorsal Raphe Nucleus.
        3. The Median Raphe Nucleus.
        4. The Supralemniscal Region.
    B. Ultrastructure
        1. Sources of Extracellular 5-HT in Rostral Raphe Nuclei
        2. Cell Bodies Found in the 5-HT Nuclei.
    C. Afferents to Midbrain 5-HT Nuclei
    D. Efferent Pathways and Terminal Projection Areas
        1. Efferent Pathways.
        2. Terminal Projection Areas.
III. Physiological and Pharmacological Aspects of the 5-HT System
    A. Firing Activity of 5-HT Neurons
        1. Autoregulation of 5-HT Neuron Firing Activity.
        2. Role of Non-5-HT Receptors in the Regulation of 5-HT Neuron Firing Activity.
        3. Heteroregulation of 5-HT Neuron Firing Activity.
    B. Effect of Antidepressant Drug Administration on 5-HT Neuron Firing Activity
    C. 5-HT Release
        1. Neurotransmitter Release and Its Regulation: Cellular and Molecular Aspects.
        2. Physiological Role of Extracellular 5-HT Bioavailability in Midbrain Raphe Nuclei.
        3. Autoregulation of 5-HT Release in the Raphe Nuclei.
        4. Heteroregulation of Neurotransmitter Release in Midbrain Raphe Nuclei.
        5. Autoregulation of 5-HT Release in Terminal Projection Areas: Cortex and Hippocampus.
        6. Heteroregulation of Neurotransmitter Release from 5-HT Fibers in Cortex and Hippocampus.
        7. 5-HT1B versus 5-HT1D Receptors.
    D. Effect of Antidepressant Drug Administration on 5-HT Release
        1. Administration of 5-HT Reuptake Blockers.
        2. Prolonged Administration of MAOIs.
        3. Antidepressants with alpha 2 Adrenoceptor Antagonistic Properties.
        4. Activation of 5-HT1A Receptors by 5-HT1A Agonists.
    E. 5-HT Reuptake
        1. Molecular Characteristics of the 5-HT Transporter (SERT).
        2. The Mechanism of 5-HT Uptake.
        3. Anatomical and Cellular Localization of the SERT.
        4. Pharmacological Properties of the SERT.
        5. Tianeptine, a Class by Itself?
    F. Regulation of 5-HT Uptake Activity by Antidepressant Drugs
IV. Concluding Remarks
Acknowledgments
References


    I. Introduction
Top
Next
References

The existence of an endogenous vasoconstrictor in blood serum (Stevens and Lee, 1984; Brodie, 1900) and the presence in the gut of a substance that increases intestinal motility (Vialli and Ersparmer, 1933) had been known to scientists since the beginning of the century. However, it was not until the serum vasoconstrictor was identified as 5-hydroxytryptamine (5-HT)2 (Rapport et al., 1948) that it became clear that this amine was also present in the mammalian central nervous system (CNS) (Twarog and Page, 1953). Shortly after its discovery in the CNS, and based on the observation that it was heterogeneously distributed in the dog brain (Bogdansky et al., 1956), 5-HT was considered for the first time a putative neurotransmitter in the CNS. A major turning point in 5-HT neurotransmission research then came about when Fuxe and Dahlström, using Falck-Hillarp histochemical fluorescence, provided the first description of 5-HT neurons (Dahlström and Fuxe, 1964) and their projections (Fuxe, 1965). Today, it is an established fact that no region in the mammalian CNS lacks 5-HT innervation (Dahlström and Fuxe, 1964; Steinbusch, 1981, 1984; see Azmitia, 1986; Jacobs and Azmitia, 1992; Azmitia-Whitaker and Azmitia, 1995).

As a neurotransmitter, the ubiquity of 5-HT is not only anatomical but also phylogenetic. Having been identified in neurons of the cnidarian Renilla koellikeri (Umbriaco et al., 1990), it could be one of the most ancient of currently known transmitters. From primates (see Azmitia and Gannon, 1986; Törk, 1990) to Chondrichtyes (Stuesse and Cruce, 1992), the adult 5-HT system is organized into two subsystems, i.e., a rostral division with cell bodies localized in the midbrain and rostral pons, providing projections to the forebrain, and a caudal division located primarily in the medulla oblongata with descending projections to the spinal cord and brainstem nuclei. Similarities found among such divergent vertebrate brains indicate that the major nuclear organization and the 5-HT projection network have remained remarkably stable across phylogeny. In spite of its remarkable evolutionary stability (Jacobowitz and MacLean, 1978), careful scrutiny of comparative anatomical evidence indicates that differences are as important as similarities. These phylogenetic differences may be summarized as follows: in higher mammals the system has evolved toward a fast, precise type of neurotransmission in which 5-HT neurons give rise to few collaterals (Fallon and Loughlin, 1982), have a high proportion of myelinated axons, and, due to the existence of a high proportion of junctional synapses, terminal field innervation is localized. In lower mammals the system is diffuse, highly branched, unmyelinated, and nonjunctional innervation predominates in terminal fields (see Azmitia 1986; Descarries et al., 1990; Törk, 1990; Jacobs and Azmitia, 1992; Azmitia and Whitaker-Azmitia, 1995).

Because 5-HT neurons are among the first neuroblasts to differentiate, the 5-HT system is also ontogenically ancient. Indeed, in the rat brain 5-HT-immunoreactivity appears as early as gestational day 12 (Olsen and Seiger, 1972; Lidov and Molliver, 1982), tryptophan hydroxylase activity is present at fertilization, and nearly every embryonic cell contains 5-HT until the gastrula stage (Harris, 1981). The first 5-HT neurons appear in early development and are located rostrally, within the mesencephalon (Lidov and Molliver, 1982) Two days later, a more caudal rhombencephalic group appears (Wallace and Lauder, 1983). In the next sections, focus will be on the rostral group.


    II. Morphological Aspects of the 5-HT Rostral System
Top
Previous
Next
References

A. 5-HT Nuclei

Dahlström and Fuxe (1964) divided 5-HT cell clusters into nine groups (B1-9), B1 being the most caudal group of cells. Today, however, the nomenclature most frequently used refers to 5-HT cells contained within cytoarchitectonic brainstem entities known as the raphe nuclei. Rostral 5-HT neurons are not confined to midline (raphe) nuclei, they are also present in more lateralized sites of the reticular formation, especially 1) dorsal to the medial lemniscus (rat: Dahlström and Fuxe, 1964; Baker et al., 1990) and 2) dorsal to the nucleus raphe pontis oralis (Lidov and Molliver, 1982; Baker et al., 1991).

1. The Caudal Linear Nucleus. The caudal linear nucleus (CLN), described in primates by Törk (1990) and Azmitia (see Azmitia, 1986; Azmitia and Gannon, 1986; Jacobs and Azmitia, 1992; Azmitia and Whitaker-Azmitia, 1995), is the most rostral group of serotonergic neurons in the mesencephalic midline, extending along the rostral boundary of the superior cerebellar decussation. Its ventral limit is defined by the interpeduncular nucleus and dorsally it contacts the dorsal raphe nucleus (DRN) through the gap left between the two medial longitudinal fasciculi. In rats, 5-HT neurons located rostral to the decussation of the superior cerebellar peduncle and above the interpeduncular nucleus have been considered in some cases a rostral extension of the median raphe nucleus (MRN) (Lorez et al., 1978; Parent et al., 1981). However, CLN and MRN neurons do not share common terminal projection fields (Imai et al., 1986) and display dissimilar dendritic morphology (Hornung and Fristchy, 1988). On the other hand, because DRN and CLN 5-HT neurons innervate similar terminal fields (e.g., caudate-putamen in adult rat brain; Imai et al., 1986) and share a common developmental origin (Wallace and Lauder, 1983), an alternative approach proposes that CLN neurons should be considered similar to those in DRN (see Jacobs and Azmitia, 1992).

2. The Dorsal Raphe Nucleus. The DRN is the largest of the brainstem serotonergic nuclei containing about 50% of 5-HT neurons in the rat CNS (Wiklund and Björklund, 1980; Descarries et al., 1982), 40% in the cat CNS (Wiklund et al., 1981), and 50 to 60% in the human CNS (Baker et al., 1990). Rostrally, the dorsal raphe is bound by the Edingher Westphal nucleus (III) and, caudally, it extends just ventral to the confluence of the fourth ventricle and the cerebral aqueduct (Steinbusch, 1981; Descarries et al., 1982; Imai et al., 1986; Törk, 1990; Jacobs and Azmitia; 1992). In most species, the DRN is composed of several subregions distinguished by their different cell density, morphology, and projections (Azmitia and Gannon, 1986; Baker et al., 1991; Johnson and Ma, 1993): 1) a medial portion, subdivided in turn into dorsomedial and ventromedial components, just below the cerebral aqueduct and surrounding the medial longitudinal fasciculus (MLF), respectively; 2) lateral portions or wings (much more prominent in primates than other mammals due to a lateralization process through phylogeny; Descarries et al., 1982; Azmitia and Gannon, 1986; Baker et al., 1991); and 3) a caudal component. During development (15 days of gestation), 5-HT-immunoreactive cells group themselves into two different clusters, dorsolateral and ventrolateral to the MLF (Wallace and Lauder, 1983). The dorsolateral portion will give rise to the lateral wings of the DRN, whereas the ventrolateral group will split to form the interfascicular portion of DRN and MRN. For this reason, it has been proposed that, in the primate CNS (see Jacobs and Azmitia, 1992; Azmitia and Whitaker-Azmitia, 1995), the interfascicular subregion of the DRN should be best considered an entity along with the MRN. Olzewski and Baxter (1954) had previously defined an anatomical entity, nucleus centralis superior, consisting of three groups of cells: 1) a dorsalis component situated between MLF, 2) a medialis component or MRN, and 3) a lateralis component which includes the 5-HT cells that form the ring around the nucleus reticularis pontis oralis (see Table 1). The absence of anatomical boundaries between the main rostral portion of the DRN (B7) and the main rostral portion of the MRN (B8) has also been observed in rats (Descarries et al., 1982) and cats (Wiklund et al., 1981). The main rostral component of the DRN (B7) also merges, in its rear end, with the caudal component (B6) of this same nucleus (see Jacobs and Azmitia, 1992; Azmitia and Whitaker-Azmitia, 1995). Furthermore, the latter caudal component is in continuity with the dorsocaudal portion of the MRN (see Jacobs and Azmitia, 1992; Azmitia and Whitaker-Azmitia, 1995) and the lateral wings of the DRN (Lidov and Molliver, 1982). Hence, anatomical proximity between different 5-HT cell clusters provides the ground for a network of homotypic interconnections among 5-HT neurons. Such interconnections constitute in turn the morphological ground for the high degree of cross-talk existing among 5-HT neurons at the somatodendritic level. The major implication underlying this arrangement is that the more closely knit and the larger the number of cells in a functional cluster, the more powerful will be the effect of the group on the target structure toward which it projects (Azmitia, 1986).

3. The Median Raphe Nucleus. The MRN consists of two distinct parts, i.e., a group of densely packed cells, vertically oriented and concentrated in the midline, and a second group, the paramedian columns, consisting of cells scattered in the periphery of the midline cluster (Köhler and Steinbusch, 1982). The nucleus is situated ventral to the MLF and has a rostrocaudal oblique orientation (Azmitia, 1981; Lidov and Molliver, 1982). In its rostral end, beyond the MLF, it is separated from the DRN in its rostral end by the superior cerebellar peduncle decussation. Its medial portion extends from the mesencephalic interpeduncular nucleus to the trapezoid body in the pons. Laterally, the limits of the nucleus are poorly defined toward the reticular formation (Köhler and Steinbusch, 1982), and in the rat the MRN merges laterally with the 5-HT group in nucleus raphe pontis oralis (Lidov and Molliver, 1982). The MRN forms the second largest cluster of 5-HT neurons in the mammalian CNS (Baker et al., 1990).

4. The Supralemniscal Region. The last group of 5-HT neurons to be considered corresponds to 5-HT cells in the supralemniscal region. In the rat, 5-HT cells belonging to this group are scattered along the dorsal border of the medial lemniscus and extend their dendrites in between the fiber bundles of the latter (Parent et al., 1981; Steinbusch, 1981). A similarity between supralemniscal 5-HT cells and those of the MRN was first noted by Dahlström and Fuxe (1964) in the rat CNS and has been later confirmed in primates (Hubbard and Di Carlo, 1974). In fact, the cells in the supralemniscal region may be continuous with those of the paramedian columns of the MRN (Azmitia and Gannon, 1986). Unlike rodents in which the supralemniscal cell cluster is predominantly mesencephalic, in humans it is entirely located in the pons (Baker et al., 1991).

B. Ultrastructure

In all species studied thus far, neurons containing 5-HT consist of a morphologically heterogeneous population (Steinbusch, 1981; Jacobs et al., 1984; Azmitia and Gannon, 1986; Törk and Hornung, 1990). The average cell diameter varies between 15 and 25 µm (Azmitia, 1978; Descarries et al., 1982), and, ultrastructurally, "5-HT specificity does not closely correlate with any particular neuronal configuration and/or intracellular build-up" (Descarries et al., 1982). No unique element allows to distinguish 5-HT cell bodies from non-5-HT surrounding neurons.

The average number of axosomatic boutons received by 5-HT neuron perikarya in the DRN has been quantified by Descarries et al. (1982). Although 100 µm of somatic membrane receive seven axonic boutons, the average number of spines on the same membrane length is 2.7 (Park et al., 1982). On the dendrites, the number of axonic boutons per 100-µm membrane length is roughly 60% higher than on the soma (Descarries et al., 1982). In cats and rats, the fibers contributing to these axosomatic or axodendritic contacts are non-5-HT fibers (Descarries et al., 1982; Chazal and Ralston, 1987). In primates, Kapadia et al. (1985) have described 5-HT fibers impinging on 5-HT dendrites.

1. Sources of Extracellular 5-HT in Rostral Raphe Nuclei The existence of serotonergic axon terminals in the raphe nuclei of cats and rats has been repeatedly reported (Baraban and Aghajanian, 1981; Chan-Palay, 1982; Descarries et al., 1982; Chazal and Ralston, 1987), but the terminals endowed with synaptic specializations have been found to be consistently in low numbers, ranging from "none" (Baraban and Aghajanian, 1981), "exceedingly small number" (Descarries et al., 1982), to "a few" (Chazal and Ralston, 1987). Furthermore, Baraban and Aghajanian (1981) found 5-HT fibers exclusively in axon bundles rather than in proximity to dendrites or cell bodies, and when 5-HT terminals were observed to make somatodendritic synaptic contacts, these were on non-5-HT neurons (Descarries et al., 1982; Chazal and Ralston, 1987). In the rare cases in which a 5-HT axon terminal was observed in close apposition to a 5-HT cell body, no demonstrable synaptic contact was present (Chazal and Ralston, 1987). Nonsynaptic 5-HT axon terminals are not exclusive to the raphe nuclei; they also exist in projection areas such as the cortex, striatum, and hippocampus (Descarries et al., 1990; Törk, 1990). 5-HT release therefore occurs not only from junctional but also from nonjunctional sites (Descarries et al., 1975, 1982, 1990).

The total number of 5-HT axons that reach the rostral raphe nuclei (independent of their synaptic specializations), as well as their origin, is a controversial issue in the literature. In autoradiographic studies of the rat brain, Descarries et al. (1982) reported "only few" [3H]5-HT-labeled axon terminals reaching the DRN; Chan-Palay (1982) found "numerous" such terminals; whereas Baraban and Aghajanian (1981) reported prominent labeling of unmyelinated 5-HT axons. On the other hand, using an immunohistochemical procedure, Brusco et al. (1983) found only few 5-HT axon terminals in rat DRN, whereas Chazal and Ralston (1987) concluded that, in the cat, the latter are "widely distributed and not uncommon", although "not numerous as compared to non-5-HT terminals". Furthermore, the fine structure of fibers impinging on the DRN was similar to that of 5-HT fibers found in terminal projection areas (Beaudet and Descarries, 1981), a fact that should be borne in mind when considering whether 5-HT fibers that impinge on the rostral 5-HT nuclei are collaterals or afferents from other 5-HT nuclei. In primates, using immunocytochemistry, Kapadia et al. (1985) have also reported few 5-HT axon terminals in the DRN.

In four of the five above-mentioned studies, the number of 5-HT fibers impinging on the raphe nuclei was found to be scarce. However, the extracellular concentration of 5-HT at the somatodendritic level is twice that observed in projection areas such as the cerebral cortex (e.g., 5.5 and 2.3 nM, respectively; Bel and Artigas, 1992), where the amount of axon terminals is 5.8 × 106 varicosities/mm3 (Descarries et al., 1990). It is then difficult to conceive that 5-HT fibers (collaterals or afferents from other nuclei) would be the only source of extracellular 5-HT in the dorsal raphe. An alternative and conceivably important source of extracellular 5-HT in the raphe area would therefore be the soma and dendrites of 5-HT neurons. Indeed, the existence of 5-HT neurons with vesicle-containing dendrites in the cat DRN has been reported (Chazal and Ralston, 1987). These dendrites may be divided into two different types: 1) dendrites in which vesicles were never found to be associated with any membrane specialization, and 2) vesicle-containing dendrites which have synaptic membrane specializations. It was not determined whether the two types of dendrites could belong to the same neuron. It is possible that the different types of dendrites could serve different functions: the ones lacking any junctional specialization could contribute to maintain high extracellular-extrasynaptic somatodendritic concentrations of 5-HT, whereas those bearing specializations could constitute the anatomical basis for dendrodendritic homotypic interactions between 5-HT neurons. In fact, although sometimes vesicle-containing dendrites were found to contact non-5-HT elements, most frequently they were presynaptic to other 5-HT dendrites. Apposition between 5-HT dendrites has also been described in rats (Descarries et al., 1982), rabbits (Felten and Harrigan, 1980), and primates (Kapadia et al., 1985). Synaptic specializations on dendrodendritic contacts were recognized in cats (Chazal and Ralston, 1987), as well as in the primate brain (Kapadia et al., 1985), although 5-HT dendrites containing vesicles were found only in the cat CNS. Despite these vesicle-containing dendrites being present throughout the DRN, they were infrequent as compared to dendrites that did not contain vesicles. Furthermore, 5-HT dendrodendritic synapses constituted a small portion of the total DRN synapses (Chazal and Ralston, 1987). A similar observation has been made in the substantia nigra where only a few of the total dendrodendritic contacts interconnected dopaminergic neurons (Wilson et al., 1977). Still, K+-induced depolarization evokes significant dopamine (DA) release from this region (Chéramy et al., 1983). A neurotransmitter-releasing role for 5-HT dendrites was initially proposed by Wang and Aghajanian (1977a, 1978) who observed that inhibition of 5-HT neuron firing following the stimulation of the ascending 5-HT pathway in the ventrotegmental area (VTA) was abolished by the 5-HT synthesis inhibitor p-chlorophenylalanine and restored by 5-hydroxytryptophan. It was also proposed that the latter inhibitory effect could be mediated by recurrent 5-HT axon collaterals. Since their initial reports (Wang and Aghajanian, 1977a, 1978), recurrent inhibition of 5-HT neuron firing activity has been confirmed using intracellular (Park et al., 1982) and extracellular (Piñeyro et al., 1996b) recordings. In the former study, the injection of horseradish peroxidase into a representative 5-HT neuron that showed recurrent inhibition following VTA stimulation revealed a single collateral arising from the neuron's axon. Although this observation supports the existence of axon collaterals, it is not evident that they constitute the only or even an important anatomical substrate for recurrent inhibition of 5-HT neuron firing activity. Moreover, two major Golgi studies in rat and rabbit (Felten and Cummings, 1979; Díaz-Cintra et al., 1981) described only a few axon collaterals. Summarizing the above-mentioned evidence, it seems reasonable to conclude that the main source of extracellular 5-HT within the raphe nuclei is of somatodendritic origin.

2. Cell Bodies Found in the 5-HT Nuclei. Quantitative studies of the total number of 5-HT neurons located in the ascending raphe nuclei indicate that there are about 288,000 in the human brain (Törk, 1990), 33,000 in the cat brain (Wiklund et al., 1981), and 15,200 in the rat brain (see Jacobs and Azmitia, 1992). Moreover, 5-HT neurons represent but a small percentage of the total neuronal population of the raphe nuclei. Using histofluorescence-imaging techniques, Wiklund et al. (1981) reported that in the cat 5-HT neurons constitute 70% of medium-sized cells in the dorsal raphe and 35% of medium-sized neurons of the MRN. This percentage could be lower, serotonergic cells constituting 25 to 50% of the total DRN neuronal population and 20 to 30% of the MRN's. In the supralemniscal 5-HT cell group (B9), the percentage of 5-HT neurons appears to be much lower than in the other two nuclei (O'Hearn and Molliver, 1984).

Non-5-HT cells reported in the mesencephalic raphe nuclei include peptidergic and nonpeptidergic neurons. The most numerous non-5-HT perikarya are the peptidergic enkephalin-immunoreactive cells (Uhl et al., 1979; Moss et al., 1981, 1983). Most of enkephalin and 5-HT immunoreactivity in dorsal and median raphe nuclei do not colocalize, thus indicating that enkephalin- and 5-HT-immunopositive cells should be best considered distinct neuronal populations (Tanaka et al., 1993). Other peptides contained in DRN somata include 1) Substance P, abundant in lateral wings (Moss et al., 1983; Magoul et al., 1986) and rostral portion of the nucleus (Ljungdahl et al., 1978). It is worth noting that in bulbospinal neurons Substance P reduces the affinity and increases the density of [3H]5-HT-binding sites (Agnati et al., 1983), indicating that the neuropeptide released from 5-HT neurons may modulate receptor sensitivity to 5-HT; 2) neurotensin, found in cells dorsal to the MLF at mid- and caudal levels of the DRN (Beitz, 1982); 3) neurons positive for vasointestinal polypeptide (VIP), which are few and located just ventral to the aqueduct (Sims et al., 1980; Moss et al., 1983); and 4) somatostatin- and cholecystokinin (CCK)-positive cells, both found within the periaqueductal gray, but few of them lie within the DRN (Vanderhaeghen et al., 1980).

There is also consistent evidence indicating the existence of DA-positive cells in the midbrain raphe nuclei (Hökfelt et al., 1976; Ochi and Shimizu, 1978; Miachon et al., 1984; Trulson et al., 1985; Descarries et al., 1986). Except for Miachon et al. (1984) who reported few tyrosine hydroxylase-positive DA-beta -hydroxylase-negative neurons, there is general agreement that DA cell bodies in the midbrain raphe are numerous. Two primary subpopulations of DA neurons have been described: 1) A10dc, lying on the extreme dorsal border of the rostral half of the DRN, ventral to the cerebral aqueduct and 2) A10c, occupying the medial aspect of the DRN and extending dorsocaudally from the ventrorostral border of this nucleus, where the cells appear contiguous with those of A10 (Hökfelt et al., 1984). Similar to A10 DA neurons, DA-containing cells in rat DRN project to nucleus accumbens (Stratford and Wirtshafter, 1989) and neostriatum (Descarries et al., 1986) with a low degree of colateralization. This projection pattern differs from that of surrounding 5-HT-immunoreactive neurons which show profuse colateralization and innervate other structures such as septum (de Olmos and Heimer, 1980), prefrontal cortex (O'Hearn and Molliver, 1984; Waterhouse et al., 1986; Imai et al., 1986), and neostriatum (Jacobs et al., 1978; Imai et al., 1986). Stratford and Wirtshafter (1989) have thus suggested that DRN DA cells represent a caudal extension of A10 and hence a completely different population from 5-HT neurons. Furthermore, no colocalization of 5-HT and tyrosine hydroxylase was observed in the raphe nuclei (Vanhatalo et al., 1995). Norepinephrine-positive cells have not been found within the DRN, but are located just caudal to the lateral wing groups at the limits of the locus ceruleus (Grzanna and Molliver, 1980).

The existence of gamma -aminobutyric acid (GABA) in midbrain raphe nuclei has been repeatedly reported (Massari et al., 1976; Belin et al., 1979; Gamrani et al., 1979; Nanopoulos et al., 1982; Harandi et al., 1987). In fact, there is as much glutamate decarboxylase activity (a specific marker for GABAergic neurons; Fonnum and Walberg, 1973; Ribak et al., 1976) in DRN as in cerebellar GABA-rich nuclei (Massari et al., 1976). The failure to obtain important changes in gamma -aminobutyric acid decarboxylase activity after lesioning afferents to the DRN, as well as the presence in this nucleus of terminals, dendrites, and nerve cell bodies accumulating [3H]GABA (Belin et al., 1979), support the notion that the GABAergic network is predominantly intrinsic to the raphe. GABA-positive cell bodies are less numerous than those for 5-HT (Belin et al., 1979; Harandi et al., 1987), and in one of these studies, 40% of the GABA-positive somata was found to contain 5-HT, whereas 30% of the 5-HT-containing neurons immunostained for GABA (Harandi et al., 1987). Hence, it was proposed that some neurons could be both GABAergic and serotonergic. Coexistence of 5-HT and GABA in midbrain raphe neurons has been repeatedly reported (Nanopoulos et al., 1982; Gamrani et al., 1984; Harandi et al., 1987; Gao et al., 1993); however, the proportion and the nuclei in which colocalization occurs vary among different studies. For example, electron microscopy studies revealed coexistence of both neurotransmitters in the somata of DRN neurons (Harandi et al., 1987). On the other hand, confocal microscopy studies revealed that in DRN and MRN, 5-HT and GABAergic neurons constitute two largely distinct populations, double-labeled neurons being observed only within the raphe magnus, raphe obscurus, and raphe pallidus nuclei (Gao et al., 1993). The latter results have been confirmed by Stamp and Semba (1995) who also observed that in raphe sections only a very small percentage of 5-HT neurons in the medullary raphe nuclei also contain GABA (raphe magnus is the nucleus where the percentage of colocalization was highest and it reached only 3.6%). In the latter study, double-labeled cells were virtually absent in the midbrain raphe nuclei, constituting 0.1 to 0.7% of the total number of cells in DRN, MRN, and the supralemniscal region. Low occurrence of colocalization of 5-HT and GABA has also been found in cultured 5-HT neurons obtained from the ponto-mesencephalic region of neonatal rats (Johnson, 1994a). The use of postnatal rat midbrain-pontine 5-HT-neuron culture has also provided evidence for corelease, and hence colocalization, of 5-HT and glutamate from single 5-HT neurons (Johnson, 1994b). However, the major drawback of the latter technique is that the possibility of glutamatergic function having developed in culture may not be ruled out. Contrary to this last possibility is the fact that coexistence of 5-HT and glutamate in rat and primate brain has been observed in medullo-spinal pathways (Nicholas et al., 1992). 5-HT has also been found to colocalize with the trace amine tryptamine (Dabadie and Geffard, 1993) and with basic fibroblast nerve growth factor (bFGF) in DRN and MRN (Chadi et al., 1993). However, bFGF lacks the signal peptide necessary to be secreted by the classical exocytotic pathway used by neuropeptides (Mignatti et al., 1992) but is released when cells are injured. Rather than as a neurotransmitter, bFGF would then act as an autocrine and paracrine factor which elicits trophic responses. Indeed, a neurotrophic role has been postulated for 5-HT itself (for review, see Jacobs and Azmitia, 1992; Azmitia and Whitaker-Azmitia, 1995). Finally, colocalization of 5-HT and NADPH diaphorase in mesopontine neurons suggest that 5-HT neurons and nitric oxide may be used as neurotransmitters by the same neuron (Johnson and Ma, 1993; Wotherspoon et al., 1994).

C. Afferents to Midbrain 5-HT Nuclei

Afferent connections to the raphe nuclei have been studied using multiple techniques such as lesion and axon degeneration, histofluorescence, anterograde/retrograde tracer injection, autoradiography, and immunohistochemistry (Brodal et al., 1960; Fuxe, 1965; Aghajanian and Wang, 1977; Mosko et al., 1977; Sakai et al., 1977; Baraban and Aghajanian, 1981; Kalen et al., 1985; Stratford and Wirtshafter, 1988; Marzienkiewicz et al., 1989; Behzadi et al., 1990). Results from such studies have been summarized in Table 2.


                              
View this table:
[in this window]
[in a new window]
 
TABLE 1
Designation of serotonergic cell groups in the raphe nuclei and brainstem reticular formation and the corresponding classification into the B groups


                              
View this table:
[in this window]
[in a new window]
 
TABLE 2
Afferents to the DRN

Interconnections among raphe nuclei using retrograde-tracing techniques suggest a moderate-to-high density of 5-HT input. These observations contrast with those from most of the immunocytochemical or radioautographic ultrastructural studies indicating a low number of 5-HT fibers in the rostral raphe. Mosko et al. (1977) have reported that the main source of 5-HT fibers reaching the DRN arise either from the DRN itself or the MRN. The latter input has been confirmed by other groups (Sakai et al., 1977; Aghajanian and Wang, 1977; Kalen et al., 1985; Vertes and Kocsis, 1994). However, given the proximity between injection and labeled sites, it cannot be ruled out that tissue damage and tracer diffusion may account for part of the retrograde staining observed in the MRN after tracer injection into the DRN. Furthermore, since retrograde transport of horseradish peroxidase by dendrites has been reported (Smith et al., 1974), this raises the possibility that the accumulation of tracer by dorsal and median raphe perikarya resulted from retrograde transport by dendrites, rather than the axon terminals of these neurons. On the other hand, tracer diffusion or retrograde dendrite transport cannot account for the projections arising from more distant nuclei (Sakai et al., 1977; Kalen et al., 1985; Marzienkiewicz et al., 1989; Behzadi et al., 1990). Histochemical confirmation of the neurotransmitter contained in connections among 5-HT nuclei has been performed on rare occasions (Stratford and Wirtshafter, 1988), and when done, numerous nonserotonergic cells were retrogradely labeled after tracer injection into the MRN. It is then possible that not all of the retrogradely labeled fibers are serotonergic. The general impression would be that 5-HT axons connecting 5-HT nuclei are "diluted" within the dorsal and median raphe neuropil.

An important afferent area to the raphe, both in terms of selectivity and density, is the lateral habenula (Aghajanian and Wang, 1977; Wang and Aghajanian, 1977b). This habenular circuit appears to be comprised of both a monosynaptic GABAergic pathway (Wang and Aghajanian, 1977b; Stern et al., 1981; Park, 1987) and a polysynaptic pathway in which GABA, Substance P (Neckers et al., 1979; Nishikawa and Scatton, 1985), and excitatory amino acids serve as components (Kalen et al., 1985, 1989).

Noradrenergic fibers impinge directly onto the dendrites of 5-HT neurons (Baraban and Aghajanian, 1981), producing an excitatory input on the firing activity of 5-HT neurons (Baraban and Aghajanian, 1980). The lateral hypothalamus also gives rise to a monosynaptic excitatory input to the DRN (Aghajanian et al., 1987) although the transmitter is unknown. Multiple afferent fibers immunoreactive for different neuropeptides, such as beta -endorphin (Bloom et al., 1978), Substance P (Ljungdahl et al., 1978; Shults et al., 1984), neurotensin fibers (Uhl et al., 1979), CCK fibers (Vanderhaeghen et al., 1980), CLIP/adrenocorticotrophic hormone (ACTH) fibers (Romagnano and Joseph, 1983; Zheng et al., 1991; Léger et al., 1994), and VIP fibers (El Kafi et al., 1994), have also been described.

D. Efferent Pathways and Terminal Projection Areas

1. Efferent Pathways. The rostral 5-HT nuclei are the main source of 5-HT fibers projecting to telencephalon and diencephalon (Fuxe, 1965; Azmitia and Segal, 1978; Parent et al., 1981; Villar et al., 1987). Although the main contingent of fibers from these nuclei is ascending, they also innervate more sparely numerous brainstem structures (Vertes and Kocsis, 1994), the cerebellar cortex (Waterhouse et al., 1986; Zimny et al., 1988), and the spinal cord (Skagerberg and Björklund, 1985). In the nonhuman primate brain, two main ascending bundles have been described, a dorsal bundle (immediately ventral to the MLF), which receives fibers mainly from lateral wings and the ventromedial portion of the DRN, and a ventral bundle, which receives fibers from the midline DRN and MRN (Schofield and Everitt, 1981, Azmitia and Gannon, 1986). In the human fetus, two ascending axon bundles have also been observed, in the central gray, ventral to the fourth ventricle and the aqueduct ependyma, and between ventromedial and ventrolateral 5-HT groups (Nobin and Bjorklund, 1973). In the rat CNS, two major projection systems to the forebrain have also been described, a transtegmental system, which probably corresponds to the above-mentioned ventral bundle, courses through the midbrain forebrain bundle (MFB) and is the most prominent of the two systems described by Descarries in the rat brain, and a periventricular system, dorsally located along the longitudinal fasciculus of Schütz (Parent et al., 1981). In primates, unlike in rats, the dorsal component (dorsal raphe cortical tract) is much more developed than the MFB system, presumably due to an increase in fibers projecting to the cortex through the dorsal pathway. Moreover, the percentage of myelinated 5-HT fibers in rat MFB is 0.7% of the total immunoreactive 5-HT fibers, whereas it is as much as 25% in primate MFB (Azmitia and Gannon, 1983).

2. Terminal Projection Areas. Dorsal and median raphe nuclei each innervate specific terminal areas (Bobillier et al., 1975; Azmitia and Segal, 1978; Jacobs et al., 1978), and, in turn, each terminal projection area has its unique topographic representation within the respective nuclei. Labeling studies using wheat germ agglutinin, horseradish peroxidase, or fluorescent dyes have been used to unveil the midbrain raphe projection network. The more rostral portions of the midbrain raphe relate to the basal-ganglia-motor system and caudal areas are more related to the limbic system. Neurons projecting to the striatum occupy the caudal linear nucleus and a rostral portion of the DRN (Jacobs et al., 1978; Imai et al., 1986), whereas those projecting to substantia nigra (Imai et al., 1986) and the motor cortex (O'Hearn and Molliver, 1984; Waterhouse et al., 1986) reside within the rostral portions of the dorsal raphe (Imai et al., 1986). Hippocampus-projecting neurons are situated caudally in the DRN (caudal ventromedial portion and B6), the MRN, and B9 (Jacobs et al., 1978; Köhler and Steinbusch, 1982; Imai et al., 1986), similar to neurons projecting to the locus ceruleus (Imai et al., 1986) and to the entorhinal cortex (Köhler and Steinbusch, 1982). The raphe representation of the amygdala, on the other hand, bridges the "basal-ganglia-motor system" and the "limbic system representation" (Jacobs et al., 1978; Imai et al., 1986), possibly as a reflection of the functional diversity of amygdaloid nuclei. The consequence of this topographic arrangement is that the selective activation of a given functional group would simultaneously influence interconnected brain circuits. Neurons projecting to interrelated brain circuits, such as the sensorimotor cortex and cerebellar crus II, the visual cortex and cerebellar paraflocculus (Waterhouse et al., 1986), or to the substantia nigra and caudate-putamen (Imai et al., 1986), the entorhinal cortex and hippocampus (Köhler and Steinbusch, 1982), the trigeminal sensory complex and nucleus accumbens or amygdala (Li et al., 1993), arise from overlapping areas within the different nuclei. Moreover, in these regions, a single neuron may provide a common input to two different but functionally interrelated terminal areas. In the ventromedial portion of the DRN, the same neuron was found to project to at least three different forebrain structures related with the limbic system: septum, medial thalamus, and olfactory cortex (de Olmos and Heimer, 1980). Colateralization provides not only a means for producing concurrent influences on numerous functionally related circuits, but it is also a way of achieving extensive serotonergic innervation from a small number of raphe neurons.

In projection areas, serotonergic axons arising from DRN and MRN raphe have been distinguished on a morphological basis: in the rat brain, dorsal raphe fibers are extremely fine with minute varicosities (less than 1 µm in diameter), whereas those arising from median raphe are distinguished by large spherical varicosities (2-5 µm in diameter; Kosofsky and Molliver, 1987; Mulligan and Törk, 1988). In neocortical areas, dorsal raphe-fine axons have been found to be far more numerous than beaded axons (Kosofsky and Molliver, 1987; Mamounas et al., 1991) and to follow a rostrocaudal pattern of distribution with a greater concentration in more frontal regions. These findings are in agreement with those obtained in retrograde-labeling experiments in which the frontal cortex received twice as many projections from cells in the DRN than those in the parietal and occipital cortex (O'Hearn and Molliver, 1984). Morphological duality has also been reported in the cat cortex (Mulligan and Törk, 1988), but such results were not replicated in the rat brain where immunostained varicosities exhibited similar shape and size irrespective of the cortical region or sector examined (Séguéla et al., 1989).

Over a wide range of doses (2.5-40 mg/kg) and survival times (1 week to 2 months), neurotoxic amphetamine derivatives, such as 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxymetamphetamine (MDMA), and p-chloroamphetamine (PCA), produce degeneration of fine 5-HT axon terminals while sparing beaded 5-HT axons (Mamounas and Molliver, 1988; O'Hearn et al., 1988; Wilson et al., 1989; Mamounas et al., 1991), as well as raphe cell bodies (O'Hearn et al., 1988; Mamounas et al., 1991). The 5-HT-releasing agent fenfluramine produces similar effects (Molliver and Molliver, 1990). These neurotoxins have been used to determine the differential distribution of beaded and fine axons and hence the contribution of DRN and MRN in different projection areas. In the hippocampus and neocortex, different neurotoxins have been reported to produce a regional axon loss/sparing pattern which is coincident with fine and beaded axon distribution. p-chlorophenylalanine (PCPA) or MDA administration caused marked denervation in the parietal and occipital cortices, and a moderate number of axons was spared in the frontal cortex (Mamounas and Molliver, 1988; Mamounas et al., 1991). In the hippocampus, there was a greater density of spared axons, most probably due to the fact that in the hippocampal formation, in comparison to other cortical areas, beaded axons are especially prevalent (Mamounas et al., 1991). An exceptionally large number of axons was spared in stratum radiatum of CA3, and intact axons were also found in the stratum oriens of CA3, stratum lacunosum of CA1, and flanking the granular layer in the dentate gyrus. In contrast, few 5-HT axons remained in the outer molecular layer of the dentate gyrus and stratum oriens and radiatum of CA1, areas that normally receive DRN innervation (Mamounas et al., 1991). On the other hand, Oleskevich and Descarries (1990) described 5-HT axons projecting to the same layers, but no distinction between fine or beaded fibers was made. This same group has nevertheless reported that 5-HT varicosities with synaptic membrane specializations are slightly larger than their nonjunctional counterparts (Oleskevich et al., 1991). In fact, based on the observation that fine fibers rarely make synaptic contacts while larger varicosities found on beaded axons tend to show distinct synaptic specializations, Törk (1990) proposes that, along with dual morphology and distinct sensitivity to neurotoxins, the existence of axons with and without synaptic contacts supports the idea that the ascending raphe projections form a dual system. It should be noted that the reported percentages of synaptic incidence in terminal areas are very variable: 30 to 80% (of a total of 5.8 × 106 varicosities/mm3) in the rat cortex (Papadopoulos et al., 1987; Séguéla et al., 1989), 3% in the monkey cortex (de Felipe and Jones, 1988), 10 to 15% (of a total of 2.6 × 106 varicosities/mm3) in the rat neostriatum (Soghomonian et al., 1987), and 18 to 24% in the hippocampus (of a total of 2.7 × 106 varicosities/mm3; Oleskevich et al., 1991).


    III. Physiological and Pharmacological Aspects of the 5-HT System
Top
Previous
Next
References

A. Firing Activity of 5-HT Neurons

Midbrain raphe 5-HT neurons exhibit a spontaneous, slow (1-5 spikes/s), regular discharge pattern (Aghajanian and Vandermaelen, 1982; Vandermaelen and Aghajanian, 1983). Intracellular recordings from dorsal raphe neurons reveal that 5-HT cells undergo repetitive cycles of interspike hyperpolarization and depolarization, spikes arising from depolarizing ramps rather than from excitatory postsynaptic potentials (Aghajanian and Vandermaelen, 1982; Vandermaelen and Aghajanian, 1983). The ionic basis for this electrical activity is summarized in Fig. 1.



View larger version (12K):
[in this window]
[in a new window]
 
Fig. 1.   Representative voltage tracings obtained from acutely isolated DRN neurons under current clamp (modified from Penington et al., 1991). A, spontaneous activity exhibited by the cell at resting membrane potential. Typical action potentials consist of an initiating ramp of depolarization, spike, shoulder upon repolarization, and an after-hyperpolarization. B, depolarization of a cell bathed with the Na+ channel blocker TTX. TTX abolished the fast component of the action potential and uncovered low- and high-threshold Ca2+ components of the action potential. Although T channels seem to be responsible for the low-threshold current, at least three different channel types (including N- and L-type) underlie the high-threshold current (Penington and Kelly, 1990; Penington et al., 1991). The after-hyperpolarization that follows, as in many other vertebrae and invertebrae neurons, is mediated by a Ca2+-activated K+ outward current (Vandermaelen and Aghajanian, 1982; Aghajanian, 1985; Aghajanian et al., 1987). This after-hyperpolarization is responsible for a long-lasting refractory period and the slow firing rate of 5-HT neurons. As Ca2+ that entered during the action potential is sequestered/extruded, the Ca2+-dependent K+ current and the after-hyperpolarization decrease. When the membrane potential reaches again the value for the low-threshold Ca2+ current (approximately -60 mV), a new spike will be triggered. As repolarization from membrane potentials below the resting potential takes place, a voltage-dependent outward K+ current that slows the rate of depolarization is simultaneously activated, the so-called IA current (Aghajanian, 1985).

In freely moving cats, regular stereotyped intrinsic activity of 5-HT neurons remains unchanged over exposure to a hot environment or administration of a pyrogen, increase in blood pressure, insulin-induced hypoglycemia, administration of painful stimuli, physical restraint, or exposure to powerful aversive stimuli (see Jacobs and Fornal, 1993). However, the basic pattern of activity is not constantly the same, and it has been shown to change dramatically during the sleep-wake-arousal cycle. Firing activity progressively slows down from an aroused state through quiet waking and slow wave sleep (SWS), to become almost silent during rapid eye movement (REM) sleep (for review, see McGinty and Harper, 1976; Jacobs and Fornal, 1993). The suppression of firing of 5-HT neuron during REM sleep correlates well with the production of muscle atonia secondary to inhibition of motoneurons controlling antigravity muscles (Trulson et al., 1981; Steinfels et al., 1983). More recently, a relationship between motor output and 5-HT neuron activity has been observed. During quiet wakefulness, when cats engage in various types of stereotyped oral-buccal activities such as chewing and biting, licking, or grooming with the tongue, approximately 25% of DRN and MRN increase their firing activity 2- to 5-fold (see Jacobs and Azmitia, 1992; Jacobs and Fornal, 1993). This increased neuronal activity precedes the onset of stereotyped motor behaviors and ends with its offset; it does not occur during purposive episodic movements, but some of the neurons may be activated by somatosensory and proprioceptive stimulations of the head and neck area. These data have given support to the current motor hypothesis of 5-HT function in which the primary role of the 5-HT system would be facilitation of motor output and concurrent inhibition of sensory information processing (Jacobs and Fornal, 1993).

The firing activity of midbrain 5-HT neurons is controlled by two main mechanisms, i.e., autoregulatory influences arising from 5-HT neurons themselves and heteroregulation by local neurons or afferents to the raphe nuclei.

1. Autoregulation of 5-HT Neuron Firing Activity. The firing rate of 5-HT neurons is decreased by 5-HT, and this effect is mediated by somatodendritic 5-HT1A autoreceptors (Aghajanian et al., 1972; Vandermaelen et al., 1986; Blier and de Montigny, 1987). 5-HT and 5-HT1A agonists inhibit 5-HT firing activity by inducing membrane hyperpolarization which is brought about by a 2-fold mechanism, i.e., by increasing conductance to potassium ions (Aghajanian and Lakoski, 1984; Yoshimura and Higashi, 1985) and by reducing a high-threshold Ca2+ current (Fig. 1; Penington and Kelly, 1990; Penington and Fox, 1994). In both cases, the response to 5-HT is G protein-mediated via a direct interaction between G proteins and the respective ion channel (Innis and Aghajanian, 1987; Penington et al., 1991; Penington et al., 1993; Penington and Fox, 1994).

Current knowledge of the pharmacological properties of somatodendritic 5-HT1A autoreceptors is mostly based on electrophysiological studies done in vivo which have assessed the effect of different compounds on the firing activity of 5-HT neurons. Table 3 summarizes these effects. Of the synthetic 5-HT1A agonists listed therein, lysergic acid diethylamide (LSD) and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) are among the most effective in producing suppression of firing activity, not only of DRN 5-HT neurons but also that of CA1/3 hippocampus pyramidal neurons. Unlike 8-OH-DPAT which produces maximal activation of postsynaptic 5-HT1A receptors, most of the drugs that completely inhibit 5-HT neuron firing activity produce partial agonistic effect at postsynaptic 5-HT1A sites in CA1 and CA3 regions of the hippocampus (Yocca and Maayani, 1985; Yocca et al., 1986; Andrade and Nicoll, 1987a). Some of these compounds (e.g., tandospirone and flesinoxan) not only produce a smaller maximal response than 8-OH-DPAT but have also been shown to reduce the inhibitory effect induced by the microiontophoretic application of 5-HT onto CA3 pyramidal neurons (Godbout et al., 1991; Hadrava et al., 1995). Conversely, several compounds previously thought to act as 5-HT1A receptor antagonists at postsynaptic sites have been shown to produce submaximal agonistic effects at presynaptic sites, inhibiting 5-HT neuron firing. These compounds are also best classified as partial agonists. For example, drugs like (+)-WAY 100135, NAN-190, or BMY 7378 block the inhibition induced by 5-HT1A agonists on forskolin-stimulated adenylyl cyclase activity from hippocampal membranes (Rydelek-Fitzgerald et al., 1990), block the postsynaptic neurochemical, electrophysiological, and behavioral effects of 8-OH-DPAT (Chaput and de Montigny, 1988; Sharp et al., 1990; Routledge et al., 1993; Escandon et al., 1994), but they also decrease 5-HT neuron firing activity (Vandermaelen et al., 1987; Chaput and de Montigny, 1988; Fletcher et al., 1993, Haddjeri and Blier, 1995). The suppression of raphe firing caused by NAN-190 and BMY 7378 is blocked by the beta -adrenergic/5-HT1A antagonist (±)-propranolol (Middlemiss, 1984a; Tricklebank et al., 1985; Greuel and Glaser, 1992). Similarly, the inhibition induced by SDZ 216-235 on 5-HT neuron firing is blocked by the beta -adrenergic/5-HT1A antagonist (-)-tertatolol (Lanfumey et al., 1993; Lejeune et al., 1993), further indicating that these "postsynaptic antagonists" act as partial agonists on presynaptic 5-HT1A receptors. The suppression of 5-HT neuron firing activity induced by (+)-WAY 100135 may be overcome by pretreatment with the alpha 1-adrenergic agonist phenylephrine but not by (-)-tertatolol, suggesting that the latter effect is not due to partial agonism on 5-HT1A receptors, but rather to the blockade of firing stimulating alpha 1 adrenoceptors on 5-HT neurons (Lanfumey et al., 1993). Because WAY 100635 and (-)-tertatolol have been consistently shown to block the effect of 5-HT1A agonists without affecting 5-HT neuron firing (Jolas et al., 1993; Lanfumey et al., 1993; Lejeune et al., 1993; Prisco et al., 1993; Craven and Grahame-Smith, 1994; Fletcher et al., 1994; Mundey et al., 1994; Table 3), they have been named "silent" antagonists. In spite of its lack of partial agonistic activity on somatodendritic 5-HT1A receptors, (+)-WAY 100135 does not enter into this category due to its alpha 1-adrenergic blocking properties (Lanfumey et al., 1993) which induce an observable inhibition of firing in the electrophysiological paradigm.


                              
View this table:
[in this window]
[in a new window]
 
TABLE 3
Effect of 5-HT1A active drugs on 5-HT neuron firing activity

Two classical hypotheses have been proposed to explain the distinct pharmacological properties of pre- and postsynaptic 5-HT1A receptors: 1) greater receptor reserve in somatodendritic than in postsynaptic areas (Meller et al., 1990; Yocca, 1990; Greuel and Glaser, 1992; Millan et al., 1992) and 2) different pre- and postsynaptic receptors (see de Montigny and Blier, 1992a,b). The first hypothesis sustains that if no receptor reserve exists, like in the case of the hippocampus (Yocca, 1990; Gozlan et al., 1994), partial agonists will not produce a maximal effect and may block the effect of full agonists. Conversely, if spare receptors are present, at an appropriately high dose, drugs with low intrinsic activity (i.e., partial agonists) may still elicit a maximal response and appear as full agonists. The second hypothesis, suggesting distinct 5-HT1A receptors at pre- and postsynaptic sites has been proposed to account not only for the differential pre-/postsynaptic activity of partial agonists but also to explain the following observations: 1) different rank order in the effectiveness of 5-HT1A agonists to inhibit DRN (8-OH-DPAT, gepirone > LSD > 5-HT) versus hippocampus firing activity (5-HT > gepirone > 8-OH-DPAT; Blier and de Montigny, 1987, 1990; Chaput and de Montigny, 1988); 2) preferential antagonistic effect of BMY 7378 at postsynaptic sites (Chaput and de Montigny, 1988) and of spiperone at presynaptic receptors (Lum and Piercey, 1988; Blier et al., 1989b, 1993a; Fornal et al., 1994a); and 3) differential effect of long-term administration of 5-HT1A agonists which induce desensitization of presynaptic but not of postsynaptic CA3 5-HT1A-mediated responses (Blier and de Montigny, 1994).

Over the past few years advances in molecular biology, i.e., the expression of G protein-coupled receptors (GPCRs) in surrogate cell systems, have greatly modified the way in which we understand pharmacological properties of GPCRs and consequently the mechanistic drug-receptor models used to simulate drug action (see Kenakin, 1996). The first of such models to consider that R activation by an agonist would result in R-G protein coupling, and subsequent activation of the G protein was the ternary complex model (De Léan et al., 1980). This model has been the standard by which drug-receptor interactions have been explained in the past. More recently, the observed ability of GPCRs for becoming activated independent of the presence of an agonist (Samama et al., 1993; Barker et al., 1994; Chidiac et al., 1994) has guaranteed the appearance of alternative paradigms (extended ternary complex model, Samama et al., 1993; two-state model, Leff, 1995; cubic ternary complex model, Weiss et al., 1996). All models consider that agonist-independent activity is secondary to spontaneous isomerization between the inactive (R) and active (R*) states of the receptor. Furthermore, according to all of these models, agonists have preferential affinity and stabilize the active conformation of the receptor (R*). Ligands that stabilize the resting state (R), decreasing the number of spontaneously active receptors, act as inverse agonists, and antagonists would be those drugs that present similar affinities for both, favoring neither state of the receptor. The fundamental consequence of embracing any such paradigms is that affinity, potency, and/or efficacy values should be considered receptor- and system-dependent, the basal R:R* ratio being a determinant of this dependence. Antagonists, whose effect would remain unmodified by the level of spontaneous activation, would therefore remain as the most reliable tools for receptor classification.

Because none of the drugs producing differential pre- and postsynaptic effects are neutral antagonists (note: spiperone has been recently characterized as an inverse agonist on spontaneously active human 5-HT1A receptors expressed in Chinese hamster ovary cells; Newman-Tancredi et al., 1997), it cannot be ruled out that differences in efficacy observed in DRN and hippocampus are not due to R:R* ratios. Furthermore, differential long-term desensitization of presynaptic receptors following long-term administration of 5-HT1A agonists has been attributed to differential drug efficacy in midbrain and hippocampus (see de Montigny and Blier, 1992a,b). Hence, possible different R:R* ratios could also account for the latter observation. Finally, differences in the R:R* ratio may explain a set of drugs being more efficacious in one area than in another, but it does not account for the observation that rank order of agonist efficacy may be different in two regions. The observation of different rank order of efficacy for 5-HT, gepirone, and 8-OH-DPAT in DRN and hippocampus could be due either to the presence of different 5-HT1A receptor subtypes or to the same 5-HT1A receptor protein coupling to different G proteins in the two different regions (see Kenakin, 1995 for receptor promiscuity). Paradigms which do not include G proteins in their formulation, such as the two-state model (Leff, 1995), do not account for the latter possibility. A more recent version, the three-state model (Leff et al., 1997), which allows for a single receptor to couple with two different G protein pathways, may be invoked to explain the differences in pharmacology in pre- and postsynaptic 5-HT1A receptors without the need to propose different receptor subtypes. The coupling of a single receptor to more than one G protein pathway is also addressed by the cubic ternary model. The latter paradigm has the advantage of providing yet another mechanism to explain changes in rank order of efficacy of agonists. The mechanism, known as agonist trafficking of receptor signals (Kenakin, 1995), proposes that different drugs may provoke agonist-specific receptor conformations which would selectively promote G protein coupling in response to activation by different agonists. The possibility of a given conformation being more easily favored in one structure than in another may explain the changes in agonist rank order. Furthermore, the fact that i.c.v. administration of cholera toxin does not alter responsiveness of 5-HT neurons to microiontophoretic applications of 5-HT or 8-OH-DPAT, but reduces that of CA3 neurons by 90% (Blier et al., 1993b), may also be explained by differential G protein coupling in the two regions.

Extracellular availability of endogenous 5-HT at the cell body level and tonic activation of somatodendritic 5-HT1A autoreceptors is yet another factor that may contribute to modify the effects of 5-HT1A ligands. Thus, Fornal et al. (1994a) have shown that the acute i.v. administration of the 5-HT1A agonist 8-OH-DPAT or of the partial agonists ipsapirone and buspirone was more effective in inhibiting 5-HT neuron firing activity when cats were inactive (drowsiness) than during active wakefulness (a period of higher neuronal activity, 5-HT neuron depolarization, and hence of 5-HT release). Conversely, the antagonists spiperone and WAY 100635 induced a dose-dependent increase in the firing rate of 5-HT neurons, which was evident during wakefulness but not during sleep (Fornal et al., 1994a,c) when 5-HT neurons are silent, and therefore there is very low depolarization-mediated release of 5-HT to activate somatodendritic 5-HT1A receptors. Moreover, in anesthetized rats and guinea pigs, in which 5-HT neuron firing activity resembles that of SWS, WAY 100635 had no effect on dorsal raphe neuronal firing (Fletcher et al., 1994; Mundey et al., 1994). It is also worth noting that the 5-HT1A antagonistic properties of (+)-WAY 100135 on spontaneous 5-HT neuron firing were not evident in anesthetized rats (Haddjeri and Blier, 1995), in awake freely moving cats (Fornal et al., 1994c), or in an antidromic stimulation paradigm in which 5-HT neuron firing is suppressed by somatodendritic release of 5-HT (Piñeyro et al., 1996b). Yet, at doses similar to the ones used in previous studies (0.5-1 mg/kg i.v.), (+)-WAY 100135 reversed the suppression of 5-HT neuron firing activity induced by the blockade of 5-HT uptake (Arborelius et al., 1995; Hajós et al., 1995). This observation is in keeping with the previous assumption that the action of 5-HT1A ligands on 5-HT neuron firing activity may differ according to the tonic activation of their somatodendritic autoreceptors by the extracellular concentration of 5-HT. Similarly, S-UH-301, which in the dose range of 0.5 to 4 mg/kg i.v. reduces 5-HT neuron firing, effectively blocked the suppressant effect induced by the systemic administration of selective 5-HT reuptake blocker citalopram (Arborelius et al., 1994, 1995). Moreover, pindolol, which by itself induces no change in 5-HT neuron firing activity at low doses, prevents the inhibitory effect of paroxetine and LSD on this parameter (Romero et al., 1996; Haddjeri et al., 1999).

Pindolol is an antagonist which, in the electrophysiological paradigm, discriminates between presynaptic and postsynaptic hippocampal 5-HT1A receptors. Like spiperone, pindolol blocks the effect of endogenous 5-HT on presynaptic receptors without interfering with the inhibitory effect induced on CA3 pyramidal neuron firing activity by the microiontophoretic application of 5-HT (Blier et al., 1993a; Romero et al., 1996). Moreover, pindolol, in contrast with other 5-HT1A antagonists, was recently shown to be ineffective in blocking the inhibitory effect of 5-HT1A agonists on the firing activity of CA1 pyramidal neurons in freely moving rats (Tada et al., 1999). These data do not imply that under certain experimental conditions pindolol cannot act as a 5-HT1A antagonist, as shown in the in vitro studies of Corradetti et al. (1998) carried out on hippocampus slices. WAY 100635, on the other hand, has been shown to block the effect of 5-HT on pre- and postsynaptic 5-HT1A receptors located on CA3 pyramidal neurons (Haddjeri et al., 1996). Binding studies are consistent with the latter observation, i.e., [3H]WAY 100635 behaves as an antagonist in projection areas such as the hippocampus since guanyl nucleotides fail to influence its KD and Bmax parameters (Khawaja, 1995; Khawaja et al., 1995). The presynaptic selectivity of the other silent antagonist (-)-tertatolol remains to be determined, and, for the time being, pindolol seems the only useful alternative of a presynaptic 5-HT1A antagonist to be used in clinical trials. Finally, it is also worth mentioning the case of (-)-propranolol, which in spite of its moderate affinity for 5